The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.
DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated ...
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...
Day-to-day restrictions on supersonic flight won't stop pilots from pushing the F-35 to the limits in combat, an F-35 test pilot tells Defense News. The Pentagon will have to live with limits on ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 p.m. to 4 a.m. ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...
iCenter for Paediatric Endocrinology, Diabetology, and Clinical Research, Auf Der Bult Children's Hospital, Hannover, Germany jDepartment of Endocrinology, Diabetes, and Metabolic Diseases, University ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback